Refine by
Fever Vomiting Equipment & Supplies
7 equipment items found
Manufactured by:Operon S.A. based inCuarte de Huerva (Zaragoza), SPAIN
The main clinical symptom of gastroenteritis caused byadenovirusis diarrhea, for 9 to 12 days, also occurring with fever and vomiting. ...
Manufactured by:Quidel Corporation based inSan Diego, CALIFORNIA (USA)
Worldwide, Campylobacter species are the most common cause of bacterial gastroenteritis, with 400-500 million cases of diarrhea each year.1 Infants in developing countries are at even greater risk, as are travelers to those countries.2 Campylobacter–associated gastroenteritis is estimated to affect nearly one million people a year in the U.S.3 In approximately 1 of 1000 cases, Campylobacter ...
Manufactured by:Operon S.A. based inCuarte de Huerva (Zaragoza), SPAIN
The main clinical symptom of gastroenteritis caused byadenovirus is diarrhea, for 9 to 12 days, also occurring with fever and ...
Manufactured by:The Native Antigen Company based inOxford, UNITED KINGDOM
Recombinant Chikungunya Virus-Like Particles produced in mammalian HEK293 cells. Chikungunya structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles are totally non-infectious. >90% ...
Manufactured by:BioMarin based inSan Rafael, CALIFORNIA (USA)
Vimizim (elosulfase alfa) is the first approved enzyme replacement therapy designed to address the underlying cause of Morquio A syndrome, or mucopolysaccharidosis IVA (MPS IVA) — a deficiency in the enzyme N-acetylgalactosamine-6 sulfatase (GALNS). VIMIZIM works at a cellular level to help with deficient enzyme ...
Manufactured by:BioMarin based inSan Rafael, CALIFORNIA (USA)
The first approved treatment for any form of Batten disease. Brineura (cerliponase alfa) is indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency. Brineura is the first enzyme replacement therapy to be directly administered into ...
Manufactured by:Biomed Lublin S.A. based inLublin, POLAND
Name of the Medicinal Product Gamma anty-D 50, 50 micrograms/ml Solution for injection. Qualitative and Quantitative Composition: 1 ml of the solution consists of: Human anti-D immunoglobulin 50 micrograms (250 IU) . Human protein content not less than 30 mg. Each ampoule contains 50 micrograms (250 IU) human anti-D immunoglobulin. The IgA content is not more than 50 micrograms/ml. The product is ...